Chiara Rocchi1, Conti Valentina2, Viviana Totaro3, Serena Broggi4, Simona Lattanzi4, Giovanna Viticchi3, Lorenzo Falsetti5, Mauro Silvestrini4, Laura Buratti4. 1. Neurological Clinic, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy. chiararocchi@hotmail.it. 2. Department of Respiratory Medicine, San Marino Hospital, San Marino, San Marino. 3. Neurological Clinic, Ospedali Riuniti Ancona, Ancona, Italy. 4. Neurological Clinic, Marche Polytechnic University, Via Conca 71, Ancona, 60020, Italy. 5. Internal and Subintensive Medicine, Ospedali Riuniti Ancona, Ancona, Italy.
Abstract
PURPOSE: Obstructive sleep apnea (OSA) is the most prevalent sleep-related breathing disorder, with a negative impact on cardiovascular health. Different OSA symptoms and treatment response in males and females have been reported. The aim of this study was to investigate inflammatory markers in patients with OSA and the relationship of those markers to disease severity in male and female subjects. METHODS: We considered consecutive subjects referred to the outpatient Sleep Disorder Service of the Respiratory Medicine Department, San Marino Hospital. We included patients with a diagnosis of moderate or severe OSAS and an age range of 45-80 years. Concomitant inflammatory conditions were an exclusion criterion. A polygraphic study and a blood draw for inflammatory markers were performed for each subject. RESULTS: Of 110 subjects, 59 were males. Severe OSA affected 72 subjects. We analyzed data through a 4-level categorical variable according to sex and OSA severity (moderate OSA, males; severe OSA, males; moderate OSA, females; severe OSA, females), which showed significant differences for interleukin-6 (IL-6) and C-reactive protein (CRP) levels. A significant difference in IL-6 levels with a significant ascending trend (p = 0.045) from females with moderate OSAS to males with severe OSAS emerged in our pairwise comparison for estimated marginal means. Also, a significant trend (p = 0.0001) for CRP levels from males with moderate OSAS to females with severe OSAS was shown. CONCLUSIONS: OSA and inflammation are interconnected, and both are associated with vascular diseases. Sex-related differences in OSA phenotypes may help the clinicians aim for a more personalized approach.
PURPOSE: Obstructive sleep apnea (OSA) is the most prevalent sleep-related breathing disorder, with a negative impact on cardiovascular health. Different OSA symptoms and treatment response in males and females have been reported. The aim of this study was to investigate inflammatory markers in patients with OSA and the relationship of those markers to disease severity in male and female subjects. METHODS: We considered consecutive subjects referred to the outpatient Sleep Disorder Service of the Respiratory Medicine Department, San Marino Hospital. We included patients with a diagnosis of moderate or severe OSAS and an age range of 45-80 years. Concomitant inflammatory conditions were an exclusion criterion. A polygraphic study and a blood draw for inflammatory markers were performed for each subject. RESULTS: Of 110 subjects, 59 were males. Severe OSA affected 72 subjects. We analyzed data through a 4-level categorical variable according to sex and OSA severity (moderate OSA, males; severe OSA, males; moderate OSA, females; severe OSA, females), which showed significant differences for interleukin-6 (IL-6) and C-reactive protein (CRP) levels. A significant difference in IL-6 levels with a significant ascending trend (p = 0.045) from females with moderate OSAS to males with severe OSAS emerged in our pairwise comparison for estimated marginal means. Also, a significant trend (p = 0.0001) for CRP levels from males with moderate OSAS to females with severe OSAS was shown. CONCLUSIONS: OSA and inflammation are interconnected, and both are associated with vascular diseases. Sex-related differences in OSA phenotypes may help the clinicians aim for a more personalized approach.
Authors: Jordan Gaines; Alexandros N Vgontzas; Julio Fernandez-Mendoza; Ilia Kritikou; Maria Basta; Edward O Bixler Journal: Brain Behav Immun Date: 2014-12-20 Impact factor: 7.217
Authors: Amit Khera; Darren K McGuire; Sabina A Murphy; Harold G Stanek; Sandeep R Das; Wanpen Vongpatanasin; Frank H Wians; Scott M Grundy; James A de Lemos Journal: J Am Coll Cardiol Date: 2005-08-02 Impact factor: 24.094
Authors: Valeriy A Poroyko; Alba Carreras; Abdelnaby Khalyfa; Ahamed A Khalyfa; Vanessa Leone; Eduard Peris; Isaac Almendros; Alex Gileles-Hillel; Zhuanhong Qiao; Nathaniel Hubert; Ramon Farré; Eugene B Chang; David Gozal Journal: Sci Rep Date: 2016-10-14 Impact factor: 4.379